Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | INCB099318 |
| Trade Name | |
| Synonyms | INCB-099318|INCB 099318|INCB99318|INCB 99318|INCB-99318 |
| Drug Descriptions |
INCB099318 inhibits PD-L1 (CD274), potentially resulting in antitumor activity (Journal for ImmunoTherapy of Cancer 2022;10). |
| DrugClasses | Immune Checkpoint Inhibitor 150 PD-L1 Inhibitor 15 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| INCB099318 | INCB099318 | 0 | 1 |